Opportunities for the treatment of inflammation in cardiovascular disease

Crossman, David C. (2001) Opportunities for the treatment of inflammation in cardiovascular disease. Expert Opinion on Pharmacotherapy, 2 (11). pp. 1751-1763. ISSN 1465-6566

Full text not available from this repository.

Abstract

Atherosclerosis, and the clinical presentation of atherosclerosis, both have their basic pathogenesis in inflammatory mechanisms. The use of mouse models of atherosclerosis has emphasised the importance of inflammation in atherogenesis, and the use of serum markers of inflammation in epidemiological studies has shown the importance of inflammatory status in determining the presentation of atherosclerotic disease. Therapeutic opportunities will arise from the manipulation of these inflammatory mechanisms. Proof of this principle has been shown with the use of aspirin and statin drugs as well as the emerging roles for peroxisome proliferator-activated receptor (PPAR) agonists. It is likely that both refinement of existing anti-inflammatory agents and the identification of new inflammatory mechanisms will afford real opportunities for the treatment of atherosclerotic cardiovascular disease.

Item Type:	Article
Uncontrolled Keywords:	sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Norwich Clinical Trials Unit
Depositing User:	Rhiannon Harvey
Date Deposited:	17 May 2011 14:37
Last Modified:	15 Dec 2022 01:44
URI:	https://ueaeprints.uea.ac.uk/id/eprint/30678
DOI:	10.1517/14656566.2.11.1751

Actions (login required)

View Item